JPMorgan says own this drug stock. It's one Jim Cramer is itching to buy again
The Club remains optimistic about Bristol Myers and shares JPMorgan's enthusiasm about Cobenfy.
You are not logged in so some information on this page has been withheld. To see more, please log in.
Cobenfy
since
auto-detected in 3 stories
82 days ago
page 1 of 1